Belif Lab and Source Music previously sued Min Hee-jin for large sums of money.
Min Hee-jin, former CEO of Adore, counter-sued CEO Tae-ho Kim and working staff of BeliFrap, a label under Hive, on charges of defamation.
On the 22nd, former CEO Min’s legal representative, Sejong Law Firm, issued a statement and said, “On this day, former CEO Min filed a complaint with the Yongsan Police Station against Belif Lab’s CEO Kim Tae-ho and executives on charges of defamation under the Information and Communications Network Act,” adding, “In addition, 50 people were filed against Belif Lab. “We are filing a lawsuit seeking damages worth billions of won,” he said.
The legal representative said, “CEO Kim Tae-ho ‘unrepresented’ that former CEO Min had delayed the civil suit filed by Belif Lab, which is clearly false,” and added, “The counterclaim filed by former CEO Min Hee-jin in the first argument to be held in January next year will also be dismissed.” “We expect that a hearing will be held together, so we hope that Belif Lab will work sincerely,” he asserted.
In addition, “CEO Kim Tae-ho and others spread numerous false facts through a YouTube video on June 10 and a statement on October 7,” he said. “They were sentenced to criminal punishment commensurate with the crime, and responsibility for damages was acknowledged.” “I hope so.”
Meanwhile, former CEO Min, who left the company by resigning from his position as an executive director of Adore on the 20th, is scheduled to file a lawsuit against Belif Lab for damages on January 10th next year. Former CEO Min has consistently claimed that ‘Aillet (of Belipp Lab) plagiarized New Genes.’
However, Belif Lab filed a lawsuit for 2 billion won in damages, claiming that former CEO Min’s claims were false.
In addition, former CEO Min is also being sued by Source Music, the agency of Le Seraphim and Hive Label, for 500 million won in damages.
Source Music filed a lawsuit for damages against former CEO Min last July. Source Music did not disclose the specific amount of the lawsuit, but it is known that it filed a lawsuit against former CEO Min, demanding compensation of 500 million won for damages suffered due to charges of defamation, obstruction of business, and insults. The first hearing date for the trial is January 10th next year.
Former CEO Min has been claiming that Le Seraphim’s launching strategy copied New Genes’ strategy, but Source Music said, “CEO Min’s claim that Source Music copied his launching strategy is false,” and “Source Music is Min Hee-jin.” “We have never copied CBO’s launching strategy at the time, and we have never acknowledged the contents of Min CBO’s complaint,” he counters.
(Seoul = News 1)
-
- great
- 0dog
-
- I’m sad
- 0dog
- I’m angry
- 0dog
- I recommend it
- dog
Hot news now
How can emerging artists protect themselves from similar legal disputes in the entertainment industry?
Interview between Time.news Editor and Legal Expert on the Min Hee-jin Defamation Case
Editor: Welcome to Time.news. Today, we’re discussing the ongoing legal battles involving Min Hee-jin, the former CEO of Adore, and various parties in the K-pop industry. With us is Dr. Ji-soo Park, a legal expert specializing in media law and intellectual property. Thank you for joining us, Dr. Park.
Dr. Park: Thank you for having me. It’s a pleasure to discuss this intriguing case.
Editor: To start, could you give us a brief overview of Min Hee-jin’s current legal issues?
Dr. Park: Certainly. Min Hee-jin recently counter-sued CEO Kim Tae-ho of Belif Lab and several of its executives for defamation. This comes after Belif Lab filed a lawsuit against her, claiming she delayed their civil suit and sought damages worth billions of won. In turn, Min is also facing lawsuits from Source Music, the agency behind Le Seraphim, for claims of defamation and business obstruction.
Editor: It sounds like a web of legal disputes! What specific allegations have been made against Min Hee-jin?
Dr. Park: The core allegation from Belif Lab is that Min Hee-jin falsely represented that the company delayed proceedings, which they argue is defamatory. Min’s legal team counters that falsehoods were spread through various platforms, including a YouTube video. They’ve also stated that her claims about Belif Lab allegedly plagiarizing the marketing strategies of New Genes are rooted in a genuine complaint.
Editor: And what about the allegations from Source Music? How do they relate to Min’s claims about launching strategies?
Dr. Park: Source Music claims that Min Hee-jin’s assertions that they copied her launching strategy lack foundation. They filed a lawsuit seeking 500 million won in damages for defamation, insisting that they’ve never engaged in any copied strategies as alleged by Min. The legal contention here is quite technical, dealing with the nuance of proving what constitutes plagiarism in marketing strategies within creatively driven industries.
Editor: This is a fascinating intersection of personal disputes and broader industry politics. How do you see this affecting the K-pop industry as a whole?
Dr. Park: Legal disputes like these can have significant ramifications, particularly in a tightly knit industry like K-pop where reputation is everything. It might deter new creative endeavors or partnerships if companies are wary of being targeted by claims of intellectual theft. Transparency and ethical practices may need to be prioritized to navigate this complex landscape.
Editor: Min Hee-jin’s counterclaim has been positioned as a fight for her reputation. In your view, how critical is a public figure’s reputation in the context of legal battles?
Dr. Park: A public figure’s reputation is imperative, especially in the entertainment sector. It influences their marketability, fan support, and future career opportunities. Min’s legal action appears as both a defense of her character and an attempt to regain her standing. Winning public sentiment can sometimes be as vital as winning in court.
Editor: What do you think the outcome of these suits might look like when they hit the court next January?
Dr. Park: It’s hard to say definitively. If the court finds evidence of defamatory intent or false representation, Min could see a favorable outcome which would help clear her name. Conversely, if Belif Lab or Source Music succeed in their suits, it could potentially set a precedent in how claims of plagiarism and defamation are handled in the K-pop industry.
Editor: We’ll certainly be watching how this unfolds. Before we wrap up, do you have any advice for emerging artists based on this situation?
Dr. Park: Yes, I would advise emerging artists to keep meticulous records of their creative process. Documenting inspiration sources and collaborative work can be invaluable in defending against potential claims. Clarity in contracts and mutual respect in collaborations can also mitigate misunderstandings before they escalate into legal disputes.
Editor: Thank you, Dr. Park, for your insights into this evolving legal situation. It’s undoubtedly a significant moment in K-pop history.
Dr. Park: Thank you for having me! I look forward to seeing how this situation develops.
Editor: And thank you to our audience for tuning into Time.news. Stay with us for more updates on this and other compelling stories.